Background: Pulmonary hypertension (PH) is a serious cardiovascular complication in
patients with end stage renal disease (ESRD) undergoing hemodialysis (HD) via arterio …

Background: Pulmonary hypertension (PH) is common in end-stage renal disease (ESRD)
patients and is associated with increased all-cause and cardiovascular mortality in this …

Background. Pulmonary hypertension is a dreaded disease associated with considerable
morbidity and mortality. The pulmonary hypertension developing due to chronic respiratory …

Background: The prevalence of pulmonary hypertension (PH) is reported between 17% and
56% in hemodialysis patients. The pathogenesis of PH in hemodialysis patients is still …

Introduction Pulmonary hypertension (PH) is an underestimated cardiovascular
consequence and a mortality predictor in patients on hemodialysis (HD). Thus, we studied …

Background: Pulmonary arterial hypertension (PAH) has recently been identified as a
common complication in patients with end-stage renal disease (ESRD) who are undergoing …

Background: End-stage renal disease can result in several systemic consequences that
pose‎ a significant risk to life, such as cardiovascular disorders. Pulmonary arterial …

Background: Pulmonary artery hypertension (PAH) is linked with morbidity and mortality in
hemodialysis (HD) patients. The relationship between serum parathyroid hormone (PTH) …

Objective: To assess prevalence of pulmonary hypertension in end-stage renal disease
patients on maintenance hemodialysis. Study Design: Descriptive cross-sectional study …